This is not the most recent version of the article. View current version (11 MAY 2011)

Intervention Review

Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma

  1. Chris Williams1,*,
  2. Iveta Simera2,
  3. Clive Grafton3

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 18 APR 2002

DOI: 10.1002/14651858.CD003911

Database Title

Additional Information

How to Cite

Williams C, Simera I, Grafton C. Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003911. DOI: 10.1002/14651858.CD003911.

Author Information

  1. 1

    Royal United Hospital, Cochrane Gynaecological Cancer Review Group, Bath, UK

  2. 2

    Centre for Statistics in Medicine, Oxford, UK

  3. 3

    Vancouver Cancer Centre, Radiation Oncology, Vancouver, Canada

*Chris Williams, Cochrane Gynaecological Cancer Review Group, Royal United Hospital, Combe Park, Bath, BA1 3NG, UK. chrisjhwilliams@btinternet.com. Christopher.Williams@ubht.swest.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (11 May 2011)

View Full Article (HTML) Summary (58K)Standard (182K)Full (214K)

  1. Current Version

    Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma

    Chris Williams and Andrew Bryant

    Article first published online: 11 MAY 2011 | DOI: 10.1002/14651858.CD003911.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma

    Chris Williams, Iveta Simera and Clive Grafton

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD003911

View Full Article (HTML) Summary (58K)Standard (182K)Full (214K)